BlueNovo Biosystems.com

Medtech · Acquired

Long-read DNA sequencing system using solid-state nanopore technology with electronic detection for genomic and epigenomic analysis

bluenovobiosystems.com →
Grants
$293K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Detection of Methylation and Translocation Events by Novel Genomic Technologies$292,731
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1249NEUROVASCULAR DIAGNOSTICS, INC.——
1250CLAIRVOYANT NETWORKS, INC.—$1.0M
1251Sinopsys Surgical, Inc.—$10M
1252BlueNovo Biosystems.com——
1253Emet Surgical, Inc.—$38K
1254Agile Focus Designs, LLC——
1255SharpEyes, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.